MX9602772A - Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal. - Google Patents

Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal.

Info

Publication number
MX9602772A
MX9602772A MX9602772A MX9602772A MX9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A
Authority
MX
Mexico
Prior art keywords
microgranules
imidazole derivatives
nitro imidazole
nitro
galenic form
Prior art date
Application number
MX9602772A
Other languages
English (en)
Spanish (es)
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of MX9602772A publication Critical patent/MX9602772A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9602772A 1994-01-14 1995-01-12 Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal. MX9602772A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
PCT/FR1995/000039 WO1995019168A1 (fr) 1994-01-14 1995-01-12 Microgranules de derives de 5-nitro imidazole

Publications (1)

Publication Number Publication Date
MX9602772A true MX9602772A (es) 1997-05-31

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9602772A MX9602772A (es) 1994-01-14 1995-01-12 Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal.

Country Status (19)

Country Link
JP (1) JPH09507499A (da)
KR (1) KR100320140B1 (da)
CN (1) CN1088357C (da)
AT (1) ATE187068T1 (da)
AU (1) AU705570B2 (da)
BR (1) BR9506507A (da)
CZ (1) CZ286080B6 (da)
DE (1) DE69513632T2 (da)
DK (1) DK0739201T3 (da)
ES (1) ES2139883T3 (da)
MA (1) MA23429A1 (da)
MX (1) MX9602772A (da)
NZ (1) NZ279238A (da)
OA (1) OA10583A (da)
PL (1) PL178424B1 (da)
PT (1) PT739201E (da)
RU (1) RU2152212C1 (da)
SK (1) SK282066B6 (da)
UA (1) UA28031C2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
EP0528971B1 (en) * 1990-05-14 1999-09-01 JERNBERG, Gary R. Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
AU705570B2 (en) 1999-05-27
CN1138826A (zh) 1996-12-25
CZ286080B6 (cs) 2000-01-12
NZ279238A (en) 1998-03-25
DE69513632T2 (de) 2000-04-06
SK91496A3 (en) 1996-12-04
SK282066B6 (sk) 2001-10-08
BR9506507A (pt) 1997-09-09
CN1088357C (zh) 2002-07-31
ES2139883T3 (es) 2000-02-16
RU2152212C1 (ru) 2000-07-10
PL315530A1 (en) 1996-11-12
PL178424B1 (pl) 2000-04-28
OA10583A (en) 2002-07-10
UA28031C2 (uk) 2000-10-16
DK0739201T3 (da) 2000-05-01
KR100320140B1 (ko) 2002-07-02
ATE187068T1 (de) 1999-12-15
DE69513632D1 (de) 2000-01-05
AU1580395A (en) 1995-08-01
PT739201E (pt) 2000-05-31
MA23429A1 (fr) 1995-10-01
CZ205596A3 (en) 1996-10-16
JPH09507499A (ja) 1997-07-29

Similar Documents

Publication Publication Date Title
WO2000007979A3 (en) Compounds and compositions for delivering active agents
AU2274201A (en) Compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
EP0993831A3 (en) Compounds and compositions for delivering active agents
IL110481A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
HUP0001943A3 (en) Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them
AP1253A (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate.
HUP0203403A3 (en) New imidazole derivatives, pharmaceutical compositions containing them and their use
IL140710A0 (en) Pulmonary delivery of active agents
HUP0004225A3 (en) Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
HUP0202263A3 (en) Benzimidazole, indole and imidazo-pyridine derivatives and pharmaceutical compositions containing them
IL190215A0 (en) Novel substituted imidazole compounds, their preparation and pharmaceutical compositions comprising them
SI0918059T1 (en) Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
AU6551198A (en) Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
IL127518A (en) Substituted heterocyclic benzocycloalkenes, their preparation and pharmaceutical compositions having an analgesic effect
NZ272089A (en) Quinoline and benzimidazole derivatives; compounds, preparation and pharmaceutical compositions
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
HUP0103184A3 (en) Sulfonyl-biphenyl-methyl-substituted imidazole derivatives, their use and pharmaceutical compositions containing them
MX9602772A (es) Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal.
IL104347A0 (en) Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
HUP0001010A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees